Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteria

Hepato-Gastroenterology

Volumn 60, Issue 124, 2013, Pages 799-806

  Gugenheim, Jean ^a   Bredt, Luis César ^a   Iannelli, Antonio ^a   Decaens, Thomas ^b   Roudot Thoraval, Francoise ^b   Meyer, Carole ^c   Durand, Francois ^d   Bernard, Pierre Henri ^e   Boillot, Olivier ^f   Sulpice, Laurent ^g   Calmus, Yvon ^h   Hardwigsen, Jean ⁱ   Ducerf, Christian ^f   Pageaux, Georges Philippe ^j   Dharancy, Sebastien ^k   Chazouiileres, Olivier ^l   Cherqui, Daniel ^b   Duvoux, Christophe ^b   Hadni Bresson, Solange ^m  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d BEAUJON HOSPITAL   (France)

^e HÔPITAL PELLEGRIN   (France)

^f CROIX ROUSSE HOSPITAL   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h Hôpital Cochin ^*  (France)

ⁱ HÔPITAL DE LA CONCEPTION   (France)

^j HÔPITAL SAINT ELOI   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

more..

Author keywords

Criteria; Transplantation; Up to seven

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; TUMOR INVASION; UP7 CRITERIA; VALIDITY;

CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84879569876     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12997     Document Type: Article

References (43)

1. Pankin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156. (Pubitemid 32911406)
2. Kew MC: Hepatic tumors and cysts. In: Feldmen M, Sleisenger MH, Schrschimidt BF, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathology/Diagnosis/ Management Vol. 1. 6th ed. Philadelphia, PA: W.B. Saunders; 1998:1364-1367.
3. Bismuth H, Chiche L, Adam R, et al.: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218(2):145-151. (Pubitemid 23229140)
4. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362:1907-1917. (Pubitemid 37518510)
5. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
6. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1232.
7. Onaca N, Gary LD, Goldstein RM, Jennings LW, Klintmalm GB: Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007; 13:391-399. (Pubitemid 46444468)
8. Duffy JP, Vardanian A, Benjamin E, et al.: Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007; 246:502-509. (Pubitemid 47312148)
9. Herrero JI, Sangro B, Pardo F, et al.: Liver Transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008; 14:272-278. (Pubitemid 351425478)
10. Ravaioli M, Ercolani G, Cescon G, et al.: Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004; 10:1195-1202. (Pubitemid 39248420)
11. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al.: Impact of UCLA criteria according to pre-and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006; 12:1761-1769. (Pubitemid 44911801)
12. Parfitt JR, Marotta P, Alghamdi M, et al.: Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007; 13:543-551. (Pubitemid 46605857)
13. Leung JY, Zhu AX, Gordon FD, et al.: Liver transplantation outcomes for early- stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl 2004; 10:1343-1354. (Pubitemid 39530049)
14. Silva M, Moya A, Berenguer M, et al.: Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008; 14:1449-1460.
15. Mazzaferro V, Llovet JP, Miceli R, et al.: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10:35-43.
16. D'Amico F, Schwartz M, Vitale A, et al.: Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009; 15:1278-1287.
17. American Liver Tumor Study Group. A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigator booklet and protocol, 1998.
18. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
19. Yao FY, Ferrell L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394-1403. (Pubitemid 32496976)
20. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVlR Cooperative Study Group. Hepatology 1996; 24:289-293. (Pubitemid 26260021)
21. Peduzzi P, Concato J, Feinstein AR, et al.: Importance of events per independent variable in proportional hazards regression analysis.II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995; 48:1503-1510. (Pubitemid 26035533)
22. Klintmalm GB: Liver transplantation for hepatocellular carcinoma: a registry report of the impact of the tumor characteristics on outcome. Ann Surg 1998; 228:479-490.
23. Jonas S, Bechstein WO, Steinmuller T, et al.: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33:1080-1086. (Pubitemid 32378206)
24. Hemming AW, Cattral MS, Reed AI, et al.: Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233:652-659. (Pubitemid 32378649)
25. Marsh JW, Dvorchik I, Subotin M, et al.: The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997; 26:444-450. (Pubitemid 27328324)
26. Iwatsuki S, Dvorchik I, Marsh JW, et al.: Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 191:389-394.
27. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007; 7:2587-2596. (Pubitemid 47561609)
28. Edmonson HA, Steiner PE: Primary carcinoma of the liver: study of 100 cases among 48000 necropsies. Cancer 1954; 7:462-503.
29. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-1440.
30. Marsh JW, Dvorchik I: Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003; 9:693-696. (Pubitemid 36874455)
31. Soejima Y, Taketomi A, Yoshizumi T, et al.: Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.Transplantation 2007; 83(7):893-899. (Pubitemid 46682729)
32. Marelli L, Grasso A, Pleguezuelo M, et al.: Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann Surg Oncol 2008; 15(12):3503-3511.
33. Cescon M, Ravaioli M, Grazi GL, et al.: Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant 2010; 2010: 904152.
34. Todo S, Furukawa H: Living donor liver transplantation for adult patients with hepatocellular carcinoma. Ann Surg 2004; 240:451-461. (Pubitemid 39121339)
35. De Carlis L, Giacomoni A, Pirotta V, et al.: Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003; 196:887-897. (Pubitemid 36676550)
36. Ravaioli M, Grazi GL, Piscaglia F, et al.: Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8(12):2547-2557.
37. Roayaie S, Schwartz JD, Sung MW, et al.: Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10:534-540. (Pubitemid 38443593)
38. Tamura S, Kato T, Berho M, et al.: Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136:25-30.
39. Shetty K, Timmins K, Brensinger C, et al.: Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10(7):911-918. (Pubitemid 38979263)
40. Ho CM, Wu YM, Hu RH, et al.: Liver transplantation for patients with hepatocellular carcinoma. Transpl Proc 2004; 36:2291-2292.
41. Zavaglia C, De Carlis L, Alberti AB, et al.: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100(12):2708-2716.
42. Toso C, Asthana S, Bigam DL, et al.: Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009; 49(3):832-838.
43. Vibert E, Azoulay D, Hoti E, et al.: Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 2010; 10:129-137.